Presents a response by Srinivasa M. Bhaskara to a letter to the editor regarding the article "From Chlorpromazine to Clozapine--Antipsychotic Adverse Effects and the Clinician's Dilemma," previously published in the periodical "The Canadian Journal of Psychiatry."